NCT07321977Recruiting
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
In recent years, knowledge of neuromuscular diseases has advanced considerably, and new therapeutic avenues are beginning to emerge. The proliferation of clinical trials has created a need to identify biomarkers that are both sensitive to changes and specific to the disease. Current gait tests only consider the time factor and not the evolution of the patient's biomechanics, which may prove insufficient for patients whose symptoms generally progress slowly. Quantifying gait parameters in neuromuscular patients therefore appears necessary. This is why we propose to study markerless gait analysis in this population, which would allow for simple and effective monitoring of kinematic parameters without resorting to complex equipment incompatible with routine clinical practice.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 15 Dec 2025
- Start date
- 3 Mar 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Institut de Myologie, France
- Diseases
- Spinal muscular atrophy
- NCT number
- NCT07321977
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 3 Mar 2026 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- All volunteers
- Individuals under guardianship, curatorship, or legal protection
- Pregnant or breastfeeding women
- Non-ambulatory individuals
- Individuals with epilepsy
- Skin conditions preventing the placement of VICON motion sensors
- Asymptomatic volunteers
- Unstable respiratory or cardiac problems
- Neurological, musculoskeletal, or psychiatric problems
- Volunteers with a neuromuscular disease
- Recent trauma or serious falls (≤ 6 months)
- Individuals who have fallen more than twice in the past year and at least once in the past three months
- Use of assistive devices such as rigid knee braces or walkers
- Unstable cardiomyopathy
- Individuals awaiting diagnosis
- Medical or social conditions that could interfere with the study, as determined by the coordinating investigator or co-investigators.
Other
- Inability to comply with the protocol requirements
Criteria the registry did not label
- All volunteers
- Age between 18 and 65
- Ambulatory
- Informed consent to participate in the study
- Member of or beneficiary of a social security system
- Volunteers with a neuromuscular disease
- Confirmed diagnosis of a neuromuscular disease of genetic origin (medical document to be provided upon enrollment in the study with proof of diagnosis) belonging to the list above.
- Ability to walk for 2 minutes without assistance.
- Ability to stand up from a chair with armrests at least 3 times in 30 seconds.
- Ability to climb an inclined plane independently or with assistance to access the movement analysis room.
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre d'Exploration et d'Évaluation Neuromusculaire Coordinator of this site? Confirm its status | Paris | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.